Clinical Trial Update: A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial update for intravenous COL-144 in acute treatment of migraine; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• COL-144

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2019-12-02